Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3358 results

Sort By:

Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma

Study ID: NCT06933966
Start Date: 2025-09-01
End Date: 2032-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

observation alone

Sponsor

Center Leon Berard

Source: clinicaltrials.gov

Share:
Add to list

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Study ID: NCT06904066
Start Date: 2025-05-07
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

86

Intervention / Treatment

Aldesleukin

cyclophosphamide

fludarabine phosphate

Individual Patient TCR-Transduced PBL

TruSight Oncology (TSO) 500

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Ambrisentan Sotagliflozin and Prevention of Renal Injury; a Randomized Evaluation

Study ID: NCT06072326
Start Date: 2025-09
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

Sotagliflozin

Ambrisentan

Ambrisentan and Sotagliflozin

Sponsor

University Medical Center Groningen

Source: clinicaltrials.gov

Share:
Add to list

Canadian Prehospital Syncope Risk Score (Prehospital CSRS)

Study ID: NCT05560126
Start Date: 2025-06-01
End Date: 2027-09-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

4875

Intervention / Treatment
Sponsor

Venkatesh Thiruganasambandamurthy

Source: clinicaltrials.gov

Share:
Add to list

Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients with Hypoplastic Left Heart Syndrome (HLHS)

Study ID: NCT06461676
Start Date: 2025-08
End Date: 2028-09
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

Ventrix Bio Extracellular Matrix

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

Study ID: NCT06760676
Start Date: 2025-12-01
End Date: 2027-07-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

90

Intervention / Treatment

Pulsed low dose rate radiotherapy (PLDR)

Alpaloritovorelli antibodies

Sponsor

Anhui Provincial Hospital

Source: clinicaltrials.gov

Share:
Add to list

Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota

Study ID: NCT06134076
Start Date: 2025-09
End Date: 2026-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Unfermented chickpea

Fermented chickpea

Sponsor

Penn State University

Source: clinicaltrials.gov

Share:
Add to list

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

Study ID: NCT06839976
Start Date: 2025-05-30
End Date: 2030-02-28
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

CART19

Sponsor

Children's Hospital of Philadelphia

Source: clinicaltrials.gov

Share:
Add to list

Evaluating Evidenced Based Options for PTSD Treatment

Study ID: NCT06733376
Start Date: 2025-06-01
End Date: 2030-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

Cognitive Processing Therapy

Prolonged Exposure

Skills Training for Affective and Interpersonal Regulation

Sponsor

Rush University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Stories to Prevent (StoP) HPV Cancers

Study ID: NCT06808776
Start Date: 2025-08-01
End Date: 2027-01-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Cancer survivor narrative

Healthy eating tips

Sponsor

Milton S. Hershey Medical Center

Source: clinicaltrials.gov

Share:
Add to list